MoneyWorks4Me

Chemo Pharma Labs - Quaterly Results

27 Oct 2023 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended September 2023. The figure stood at Rs. 0.00 millions during the year-ago period.The Net Profit of the company registered a slight decline of -17.76% to Rs. 4.40  millions from Rs. 5.35 millions.The Operating Profit of the company witnessed a decrease to 4.42 millions from 5.36 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 4.60 5.90 -22.03 8.89 2.05 333.66 2.95 7.89 -62.61
PBIDT 4.42 5.36 -17.54 8.20 0.38 2057.89 0.86 3.84 -77.60
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 4.42 5.36 -17.54 8.20 0.38 2057.89 0.86 3.84 -77.60
Depreciation 0.02 0.03 -33.33 0.04 0.06 -33.33 0.13 0.19 -31.58
PBT 4.40 5.33 -17.45 8.16 0.32 2450.00 0.73 3.65 -80.00
TAX 0.00 -0.02 0.00 0.00 -0.02 0.00 0.26 -1.95 -113.33
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.04 -0.30 246.67
PAT 4.40 5.35 -17.76 8.16 0.34 2300.00 0.47 5.60 -91.61
Equity 15.00 15.00 0.00 15.00 15.00 0.00 15.00 15.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..